Pfizer Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Pfizer Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $40 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 88% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 29% of its market value (net debt). Lower than 88% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$185Over the last 3 years, every $100 of reported profit came with $185 of operating cash.
Higher than 72% of Healthcare companies in United States.
Self-Funding Ratio
3.5×Over the last 3 years its own operating cash covered its investment spending (capex) 3.5 times.
Higher than 81% of Healthcare companies in United States.
Cash Locked Ratio
$25For every $100 of sales, $25 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $13 tied up three years earlier.
More money tied up than 54% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 38%
Sales fell 38% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-38% / +6%In 3 years sales changed by -38% while total assets changed by +6%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
3.7×Debt due within a year is covered 3.7 times by its yearly operating cash.
Higher than 78% of Healthcare companies in United States.
Cash Cushion Ratio
−29%Debt, after subtracting cash, equals 29% of its market value (net debt).
Lower than 88% of Healthcare companies in United States.
Tangible Assets Ratio
40%Of every $100 the company owns, $40 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 88% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 85% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Pfizer Inc. owes $0.57 for every $1 it owns. Net profit fell 3% in the year to Dec 2025, and shrank 37% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
40.0Investors pay $40.0 for every $1 of Pfizer Inc.'s yearly profit, higher than 73% of Healthcare companies in United States.
P/B ratio
2.04The share price is 2.04 times Pfizer Inc.'s book value per share, lower than 58% of Healthcare companies in United States.
Market cap
$173.4 BThe total market value of all of Pfizer Inc.'s shares at today's price (share price × number of shares), larger than almost all Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$85.2 BWhat Pfizer Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$14.95Net worth divided by the number of shares. The share price of $30.42 is 2.0 times this, which is the P/B above.
Return on equity (ROE)
5.0%Pfizer Inc. earned 5.0% on its shareholders' money over the last year, higher than 80% of Healthcare companies in United States.
Owes vs Owns
0.57×Pfizer Inc. owes $0.57 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.
Dividend yield
5.76%Pfizer Inc. pays 5.76% of its share price as dividends a year, higher than 96% of dividend-paying Healthcare companies in United States.
Revenue growth
-2%Revenue fell 2% in the year to Dec 2025, and shrank 15% a year on average over 3 years.
Profit growth
-3%Net profit fell 3% in the year to Dec 2025, and shrank 37% a year on average over 3 years.
Profit margin
12.4%Pfizer Inc. keeps $12 of every $100 of revenue as net profit.
Cash quality
1.5×Cash from Pfizer Inc.'s business was 1.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
6.5×Pfizer Inc.'s operating profit covered its interest costs 6.5 times in the year to Dec 2025.
Cash vs debt
Net debtPfizer Inc. had $50.4 B more debt than cash (net debt) at Dec 2025.
Questions
What is Pfizer Inc.'s P/E ratio?
Investors pay $40.0 for every $1 of Pfizer Inc.'s yearly profit, higher than 73% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Pfizer Inc.: $173.4 B ÷ $85.2 B (30 Jun 2026) = 2.0.
What is Pfizer Inc.'s return on equity?
Pfizer Inc. earned 5.0% on its shareholders' money over the last year, higher than 80% of Healthcare companies in United States.
How much does Pfizer Inc. owe compared with what it owns?
Pfizer Inc. owes $0.57 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.
Does Pfizer Inc. pay a dividend?
Yes. Pfizer Inc. pays 5.76% of its share price as dividends a year, higher than 96% of dividend-paying Healthcare companies in United States.
Is Pfizer Inc.'s revenue growing?
Revenue fell 2% in the year to Dec 2025, and shrank 15% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.